Chemkart India Limited (BOM:544442)

Market Cap	1.06B
Revenue (ttm)	1.93B +54.0%
Net Income	187.87M
EPS	13.26
Shares Out	12.10M
PE Ratio	6.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	34,200
Average Volume	43,740
Open	94.50
Previous Close	90.08
Day's Range	87.00 - 94.50
52-Week Range	87.00 - 262.00
Beta	n/a
RSI	32.25
Earnings Date	Jun 24, 2026

About Chemkart India

Chemkart India Limited engages in the trading of various food and health ingredients in India. It offers amino acids, health supplements, herbal extracts, nucleotides, proteins, and vitamins, as well as sports nutrition products. The company also provides nutritional supplements and components, such as glycine, creatine monohydrate 200mesh, inositol, L-arginine, L-glutamine, L-carmitne, N-acetyl L-cysteine, taurine, L-glutathione, and whey protein concentrate. In addition, it engages in the trading and processing of nutraceutical products. The ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2020
• Employees: 40
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544442

Financial Performance

In fiscal year 2025, Chemkart India's revenue was 2.03 billion, an increase of 53.97% compared to the previous year's 1.32 billion. Earnings were 242.71 million, an increase of 67.18%.